Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study. [electronic resource]
Producer: 20091229Description: 3118-26 p. digitalISSN:- 1873-376X
- Adamantane -- analogs & derivatives
- Antineoplastic Agents -- blood
- Calibration
- Chromatography, High Pressure Liquid -- methods
- Cinnamates -- blood
- Drug Stability
- Female
- Humans
- Linear Models
- Ovarian Neoplasms -- blood
- Reproducibility of Results
- Sensitivity and Specificity
- Tandem Mass Spectrometry -- methods
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.